As reported earlier this week in Voice of America News, the Zimbabwe health ministry is making plans to target typhoid, cholera and other water-borne diseases in t

Last week in separate deals with the GAVI Alliance, the drug companies Pfizer and GlaxoSmithKline (GSK) agreed to increase sales of cut-price pneumonia vaccines by 180 million doses, a 50% increase from previous commitments.

Dr. Ciro de Quadros appointed to Decade of Vaccines (DoV) Collaboration leadership

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.
In an op-ed published Friday, Sabin president Peter Hotez, M.D., Ph.D., and his Baylor College of Medicine colleague, William Brinkley, Ph.D., applaud the dramatic gains Texas institutions have made to become leaders among the global scientific community. They cite the routinely high ranking of public and private Texas universities as well as a voter approved amendment to start the Cancer Prevention and Research Institute of Texas (CPRIT).

Gift giving can become tiresome. There is the shopping, and the wondering if your online shipment will arrive in time, or worse, actually going to a mall. There is the wrapping, but remember, not before you fly. Then, of course, there is the deflated feeling that it really doesn’t matter.

Participants gather for a “family photo” at Sabin’s First Vaccinology Course for Latin America, Lima, Peru, 12-16 December 2011.

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

Merck Serono plans to double its donation from 25 million tablets to 50 million tablets and will continue a commitment to donations indefinitely, until schistosomiasis has been eliminated in Africa.

We're at the beginning of something big.

Pages